10685332

Fox R

1999

Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.

10685333

Waggoner W

1999

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.

10685334

Schally AV

1999

LH-RH analogues: I. Their impact on reproductive medicine.

10685525

Hacihanefioglu B

2000

Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome.

10685526

Felemban A

2000

Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal.

10685546

Liu X

2000

Effects of recombinant human FSH (rhFSH), urinary purified FSH (uFSH), and hMG on small preantral follicles and tertiary follicles from normal adult and androgen-sterilized female mice.

10686193

Mantzoros CS

2000

Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome.

10686206

Rai R

2000

Polycystic ovaries and recurrent miscarriage--a reappraisal.

10689001

Lindheim SR

2000

Circulating leptin levels during ovulation induction: relation to adiposity and ovarian morphology.

10689004

Witchel SF

2000

No association between body mass index and beta(3)-adrenergic receptor variant (W64R) in children with premature pubarche and adolescent girls with hyperandrogenism.

10690875

Imani B

2000

Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

10693184

Plouffe L Jr

2000

Disorders of excessive hair growth in the adolescent.

10695100

Gupta S

1999

Polycystic ovarian syndrome: is community care appropriate?

10696281

Bray GA

1999

Etiology and pathogenesis of obesity.

10698182

Lara HE

2000

An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat.

10698183

Dissen GA

2000

Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat.

10703589

Fauser BC

2000

[Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders].

10707578

Sanaka M

2000

[Troglitazone for treatment of polycystic ovary syndrome].

10711825

Bukulmez O

2000

Leukocytes in ovarian function.

10714750

Chin D

2000

Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome.

10716298

Stener-Victorin E

2000

Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome.

10718837

Kokaly W

2000

Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.

10719843

Sun F

2000

The effect of a special herbal tea on obesity and anovulation in androgen-sterilized rats.

10720020

Villa V

2000

Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.

10720029

Chang PL

2000

Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.

10730388

Rachev E

1999

[Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].

10731530

Ciampelli M

2000

Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome.

10731531

Tartagni M

2000

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.

10731532

Winters SJ

2000

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.

10731533

Wu X

2000

Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.

10731534

Diamanti-Kandarakis E

2000

Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome.

10731545

Gallinelli A

2000

Autonomic and neuroendocrine responses to stress in patients with functional hypothalamic secondary amenorrhea.

10732317

Qin KN

2000

Expression of 17 beta-hydroxysteroid dehydrogenase type 5 in human ovary: a pilot study.

10733310

Toledo SP

2000

Inactivating mutations in the LH receptor-as rare as a hen with teethor as frequent as polycystic ovary syndrome?

10733311

McDonough PG

2000

Inactivating mutations in the LH receptor-as rare a a hen with teeth or as frequent as polycystic ovary syndrome?

10734677

B?rzashki I

1999

[Laparoscopic fenestration of the ovaries in sterility and the Stein-Leventhal syndrome--is it a modern fad or correct procedure].

10734678

Kolarov G

1999

[The use of the preparation Anteovin in dysfunctional uterine hemorrhages and PCOS].

10734682

Rachev E

1999

[Polycystic ovary syndrome. II. The current therapeutic approach].

10739813

Suikkari AM

2000

Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes.

10739820

Cibula D

2000

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

10749978

Stead JD

2000

Allele diversity and germline mutation at the insulin minisatellite.

10751596

Vogeser M

2000

Corticosteroid-binding globulin and unbound serum cortisol in women with polycystic ovary syndrome.

10756492

Hagag P

2000

Diagnosis of polycystic ovary disease in obese women with a 24-hour hormone profile after buserelin stimulation.

10756770

Ghemigian A

1997

[The etiopathogenetic hypotheses in polycystic ovary].

10758797

Sengos C

2000

Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome.

10762292

Atiomo WU

2000

Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).

10770198

Nordt TK

2000

Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.

10770203

De Leo V

2000

Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome.

10775522

Reuber M

2000

Valproate, polycystic ovary syndrome and the need for a prospective study.

10775648

Kaaijk EM

2000

Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.

10785214

Mathur RS

2000

Distinction between early and late ovarian hyperstimulation syndrome.

10785223

Pigny P

2000

Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.

10785224

Cha KY

2000

Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome.

10785225

M?derris II

2000

A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.

10786401

Antoine JM

2000

[Therapeutic management of ovarian dystrophy and insufficiency in abortion disorders: recent data].

10792338

Spritzer PM

2000

Spironolactone as a single agent for long-term therapy of hirsute patients.

10792339

Wild S

2000

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.

10796488

Hughes E

2000

Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome.

10796690

Hughes E

2000

Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.

10796718

Bayram N

2000

Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.

10796746

Farquhar C

2000

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

10799412

Godfrey KM

2000

Fetal nutrition and adult disease.

10802080

Takeuchi T

2000

Basal leptin concentrations in women with normal and dysfunctional ovarian conditions.

10804375

Dewailly D

2000

[Polycystic ovary syndrome].

10804539

Sozen I

2000

Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.

10806662

Wang A

1998

[Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].

10813104

Doldi N

2000

Polycystic ovary syndrome: evidence for reduced 3 beta-hydroxysteroid dehydrogenase gene expression in human luteinizing granulosa cells.

10813106

Vicino M

2000

Predictive value of serum androstenedione basal levels on the choice of gonadotropin or laparoscopic ovarian electrocautery as ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.

10814527

Mu YM

2000

Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.

10814602

Lakhani K

2000

Internal carotid artery haemodynamics in women with polycystic ovaries.

10817097

Piontek CM

2000

Appropriate clinical management of women taking valproate.

10817101

Rasgon NL

2000

Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.

10818406

Legro RS

2000

The genetics of obesity. Lessons for polycystic ovary syndrome.

10818407

Diamanti-Kandarakis E

2000

Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome.

10818412

Creatsas G

2000

Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.

10821224

Lewy VD

1999

Determination of body composition in African-American children: validation of bioelectrical impedence with dual energy X-ray absorptiometry.

10831553

Morin-Papunen LC

2000

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.

10843164

Mather KJ

2000

Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.

10852468

Wickenheisser JK

2000

Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.

10856463

Kim LH

2000

Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility?

10856472

Timmerman-van Kessel EC

2000

A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.

10856473

Kolodziejczyk B

2000

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

10856495

Campo S

2000

Ovarian hyperstimulation after administration of triptorelin therapy to a patient with polycystic ovary syndrome.

10856497

Hacihanefioglu B

2000

Polycystic ovary syndrome nomenclature: chaos?

10858183

Lobo RA

2000

The importance of diagnosing the polycystic ovary syndrome.

10861555

Kumar A

2000

Induction of ovulation by clomiphene citrate in the Indian vespertilionid bat, Scotophilus heathi.

10869785

Sills ES

2000

Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes.

10870780

Vollenhoven B

2000

Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins.

10871644

Liao WX

2000

Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome.

10873116

Ben-Rafael Z

2000

Polycystic ovary syndrome: a single gene mutation or an evolving set of symptoms.

10873123

Sladkevicius P

2000

Advanced ultrasound examination in the management of subfertility.

10880731

Hern?ndez I

2000

Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.

10887449

Bergfeld WF

2000

Hirsutism in women. Effective therapy that is safe for long-term use.

10891991

Isojarvi JI

2000

Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.

10895282

Kinalski M

1999

[The effect of obesity on ovarian function. I. Serum insulin and insulin dependent protein concentrations in obese patients with polycystic ovary syndrome].

10895283

Kowalska I

1999

[The influence of obesity on ovarian function. II. Plasma leptin concentration in women with polycystic ovary syndrome].

10899496

van Hooff MH

2000

Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin.

10899497

Romaguera J

2000

Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico.

10900588

Seale FG 4th

2000

Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.

10901869

Eden JA

1999

A review of 1019 consecutive cases of polycystic ovary syndrome demonstrated by ultrasound.